News Health & Medicine

A new kind of non-opioid painkiller gets FDA approval

The oral drug, called Journavx, is meant to treat short-term pain

An image of a pill bottle labeled JOURNAVX with a little blue pill beside it.

A new oral drug called Journavx is intended for the treatment of short-term pain, such as following surgery or another tissue injury.

Vertex Pharmaceuticals 

By Aimee Cunningham

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

On January 30, the U.S. Food and Drug Administration approved suzetrigine for the treatment of moderate to severe pain in adults.